Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

345 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura.
Bennett CM, Rogers ZR, Kinnamon DD, Bussel JB, Mahoney DH, Abshire TC, Sawaf H, Moore TB, Loh ML, Glader BE, McCarthy MC, Mueller BU, Olson TA, Lorenzana AN, Mentzer WC, Buchanan GR, Feldman HA, Neufeld EJ. Bennett CM, et al. Among authors: buchanan gr. Blood. 2006 Apr 1;107(7):2639-42. doi: 10.1182/blood-2005-08-3518. Epub 2005 Dec 13. Blood. 2006. PMID: 16352811 Free PMC article. Clinical Trial.
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura.
Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PH, Bennett CM, Neufeld EJ, Vesely SK, Adix L, Blanchette VS, Kühne T; Intercontinental Childhood ITP Study Group Registry II Participants. Neunert CE, et al. Among authors: buchanan gr. Blood. 2008 Nov 15;112(10):4003-8. doi: 10.1182/blood-2008-03-138487. Epub 2008 Aug 12. Blood. 2008. PMID: 18698007 Free PMC article.
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.
Mueller BU, Bennett CM, Feldman HA, Bussel JB, Abshire TC, Moore TB, Sawaf H, Loh ML, Rogers ZR, Glader BE, McCarthy MC, Mahoney DH, Olson TA, Feig SA, Lorenzana AN, Mentzer WC, Buchanan GR, Neufeld EJ; Pediatric Rituximab/ITP Study Group; Glaser Pediatric Research Network. Mueller BU, et al. Among authors: buchanan gr. Pediatr Blood Cancer. 2009 Feb;52(2):259-62. doi: 10.1002/pbc.21757. Pediatr Blood Cancer. 2009. PMID: 18937333 Free PMC article. Clinical Trial.
Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia.
Grace RF, Bennett CM, Ritchey AK, Jeng M, Thornburg CD, Lambert MP, Neier M, Recht M, Kumar M, Blanchette V, Klaassen RJ, Buchanan GR, Kurth MH, Nugent DJ, Thompson AA, Stine K, Kalish LA, Neufeld EJ. Grace RF, et al. Among authors: buchanan gr. Pediatr Blood Cancer. 2012 Feb;58(2):221-5. doi: 10.1002/pbc.23130. Epub 2011 Jun 14. Pediatr Blood Cancer. 2012. PMID: 21674758 Free PMC article.
The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology.
Bolton-Maggs P, Tarantino MD, Buchanan GR, Bussel JB, George JN; American Society of Pediatric Hematology/Oncology. Bolton-Maggs P, et al. Among authors: buchanan gr. J Pediatr Hematol Oncol. 2004 Feb;26(2):146-51. doi: 10.1097/00043426-200402000-00020. J Pediatr Hematol Oncol. 2004. PMID: 14767210
345 results